Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the Medical Sciences Division will be running activities on topics from genetic editing to chocolate.

IF Oxford is an annual science and ideas festival taking place in locations across the city. It offers a variety of events, workshops and talks to explore the latest scientific research with audiences of all ages, and creates an opportunity for thousands of face-to-face interactions between Festival visitors, researchers and innovators.This year's festival runs from 12- 22 October, and researchers from the Medical Sciences Division will be out in force!

A huge variety of events co-ordinated by Oxford Neuroscience (from departments including Experimental Psychology, Pharmacology, Physiology Anatomy and Genetics, Psychiatry and the Nuffield Department of Clinical Neurosciences) will offer visitors the opportunity to explore how the brain controls everything from our muscles to our breathing, and the techniques researchers use to find out more about it. Also don't miss 'The Consciousness Field' an interactive art installation that offers a journey through the mammalian brain. 

Another art exhibition from Meg Rahaim, the artist in residence at the Wellcome Centre For Human Genetics in Oxford for the 2017/18 academic year, will also be open to the public for the duration of the festival, and offers an insight into human genetics through the mediums of printing and crochet - find out more. 

Oxfordshire Science Festival 4© NDM Strategic

Hands on activities at a previous Festival 

Researchers from the Radcliffe Department of Medicine will be exploring genome editing, genetic sequencing, and the importance of blood through hands-on activities, talks, and virtual reality, while scientists from the Department of Biochemistry will demonstrate the wonderful world of crystals - which make chocolate taste great, and can help us to understand human diseases. Further activities run by researchers from the Nuffield Department of Medicine, NDORMS, Department of Pharmacology, Department of Paediatrics, and Department of Surgical Sciences will also offer insights into the Medical Research done at the University. 

There are hundreds more activities taking place over these ten days, so make sure you check out the IF Oxford website for a full programme. You can also find out more about how the Medical Sciences Division engages with the public here

 

Similar stories

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.